1985
DOI: 10.1159/000226070
|View full text |Cite
|
Sign up to set email alerts
|

Mouse Neoplasia and Immunity: Effects of Radiation, Hyperthermia, 2-deoxy-<i>D</i>-glucose, and <i>Corynebacterium parvum</i>

Abstract: Radiation (XRT), hyperthermia, 2-deoxy-D-glucose (2DG), and Corynebacterium parvum were given in various combinations to BALB/c mice injected with herpes virus type 2-transformed (H238) cells. Addition of heat significantly increased the antitumor effects of XRT, and the combination of XRT + 2DG + heat resulted in the highest incidence of complete tumor regression. Enhanced activity of phytohemaggluti-nin-responsive T lymphocytes and natural killer cells capable of killing YAC-1 tumor cells was noted in some o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1989
1989
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…As an initial approach,16 rats and mice were fed a diet containing 2‐deoxy‐d‐glucose (2DG), which inhibits the enzyme, phosphohexose isomerase, and thus reduces glycolytic processing. Previous studies revealed that 2DG injections could inhibit tumor growth42 and produce torpor43 and increase glucocorticoids,44 all of which paralleled effects of CR.…”
Section: ‐Deoxyglucosementioning
confidence: 95%
“…As an initial approach,16 rats and mice were fed a diet containing 2‐deoxy‐d‐glucose (2DG), which inhibits the enzyme, phosphohexose isomerase, and thus reduces glycolytic processing. Previous studies revealed that 2DG injections could inhibit tumor growth42 and produce torpor43 and increase glucocorticoids,44 all of which paralleled effects of CR.…”
Section: ‐Deoxyglucosementioning
confidence: 95%
“…For this initial study, the compound selected was 2‐deoxy‐D‐glucose (2DG), which inhibits the enzyme phosphohexose isomerase and thus reduces glycolytic processing. Results of previous rodent studies had shown that injections of 2DG could inhibit tumor growth (Gridley et al ., 1985), produce torpor (Dark et al ., 1994) and increase glucocorticoids (Weidenfeld et al ., 1994), all indicative of a CRM. In the initial evaluation of 2DG as a CRM, young male Fischer‐344 (F344) rats were fed diets supplemented (by weight) with 0.2%, 0.4%, or 0.6% 2DG, approximating doses of 100–150, 250–300, or 400–450 mg kg −1 , respectively.…”
Section: Glycolytic Inhibitionmentioning
confidence: 99%
“…Supporting data for this hypothesis include studies where 2DG has been shown to recapitulate key hallmarks of CR such as reduced body temperature (Ingram et al, 2006), increased torpor (Dark et al, 1994), reduced heart rate (Wan et al, 2003), and reduced circulating levels of glucose and insulin (Lane et al, 1998; Wan et al, 2003; Wan et al, 2004). 2DG has also been shown to confer functional benefits that parallel those seen with CR including inhibition of tumor growth (Gridley et al, 1985; Zhu et al, 2005) and increased stress resistance to neurotoxins and cold shock (Duan and Mattson, 1999; Yu and Mattson, 1999; Guo and Mattson 2000; Wan et al, 2004). 2DG has also shown potential benefits in the treatment of seizures in rodents (Stafstrom et al, 2008).…”
Section: Introductionmentioning
confidence: 99%